Concepedia

Andrew Hendifar

AH

Statistics

Publications

4

Citations

132

H-Index

4

Active since

2013

Affiliations

Sarcoma Oncology Center(Current)

Andrew Hendifar is an author at Sarcoma Oncology Center specializing in oncology, pharmacology, and cancer pharmacology.

Publications per year

2013–2016

4

Publications

4

6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

J. Strosberg, Edward M. Wolin, Beth Chasen et al. · European Journal of Cancer · 2015 · 56 citations

, , +12

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Sant P. Chawla, Arthur P. Staddon, Andrew Hendifar et al. · BMC Cancer · 2013 · 26 citations · Full text

, , +15

A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series

Run Yu, Nicholas N. Nissen, Andrew Hendifar et al. · Pancreas · 2016 · 26 citations

, , +17

A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma

Sant P. Chawla, Victoria S. Chua, Andrew Hendifar et al. · Cancer · 2014 · 24 citations · Full text

, , +15

1–4 of 4